National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Who can join
Adults 18 to 55, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
24-hour Energy Expenditure (kcal)Primary· Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
Energy expenditure (EE) as measured during 24 hours in a whole-room calorimeter
Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
2256
± 393
2. Chamber at 19°C, ad Libitum Diet First
2166
± 302
Chamber at 24°C, ad libitum diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
2563
± 422
2. Chamber at 19°C, ad Libitum Diet First
2487
± 385
Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
2271
± 360
2. Chamber at 19°C, ad Libitum Diet First
2153
± 304
Chamber at 19°C, ad libitum diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
2552
± 418
2. Chamber at 19°C, ad Libitum Diet First
2505
± 401
Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
2135
± 337
2. Chamber at 19°C, ad Libitum Diet First
1998
± 296
24-hour Energy Intake (kcal)Primary· Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
Energy intake as measured during 24 hours in a whole-room calorimeter
Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
3811
± 1140
2. Chamber at 19°C, ad Libitum Diet First
3694
± 1503
Chamber at 24°C, ad libitum diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
4091
± 1054
2. Chamber at 19°C, ad Libitum Diet First
4359
± 1404
Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
4014
± 1136
2. Chamber at 19°C, ad Libitum Diet First
4075
± 1587
Chamber at 19°C, ad libitum diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
4509
± 1255
2. Chamber at 19°C, ad Libitum Diet First
4762
± 1610
Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
3795
± 1223
2. Chamber at 19°C, ad Libitum Diet First
4112
± 1406
24- Hour Respiratory Quotient (RQ)Secondary· Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
RQ, an approximation for the ratio of carbohydrate-to-fat oxidation rates, is measured while in the chamber
Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.868
± 0.024
2. Chamber at 19°C, ad Libitum Diet First
0.868
± 0.029
Chamber at 24°C, ad libitum diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.925
± 0.056
2. Chamber at 19°C, ad Libitum Diet First
0.935
± 0.06
Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.872
± 0.02
2. Chamber at 19°C, ad Libitum Diet First
0.867
± 0.032
Chamber at 19°C, ad libitum diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.909
± 0.037
2. Chamber at 19°C, ad Libitum Diet First
0.916
± 0.045
Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.793
± 0.022
2. Chamber at 19°C, ad Libitum Diet First
0.789
± 0.03
LeptinSecondary· Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma leptin (ng/ml)
Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
26.1
± 26.4
2. Chamber at 19°C, ad Libitum Diet First
26.5
± 30.5
Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
29.5
± 30.1
2. Chamber at 19°C, ad Libitum Diet First
27.8
± 30.3
Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
18.3
± 19.9
2. Chamber at 19°C, ad Libitum Diet First
16.6
± 22.1
SecretinSecondary· Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma secretin (ng/ml)
(Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.91
± 0.22
2. Chamber at 19°C, ad Libitum Diet First
0.91
± 0.25
(Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
1.03
± 0.26
2. Chamber at 19°C, ad Libitum Diet First
1.00
± 0.25
(Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.99
± 0.24
2. Chamber at 19°C, ad Libitum Diet First
1.01
± 0.24
GhrelinSecondary· Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma grehlin (pg/ml)
Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
502
± 254
2. Chamber at 19°C, ad Libitum Diet First
644
± 274
Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
544
± 277
2. Chamber at 19°C, ad Libitum Diet First
605
± 311
Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
575
± 293
2. Chamber at 19°C, ad Libitum Diet First
581
± 304
FGF-21Secondary· Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma FGF-21 (pg/ml)
Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
94
± 73
2. Chamber at 19°C, ad Libitum Diet First
98
± 72
Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
98
± 81
2. Chamber at 19°C, ad Libitum Diet First
113
± 90
Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
106
± 66
2. Chamber at 19°C, ad Libitum Diet First
108
± 76
Core Body Temperature (C)Secondary· Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Core body temperature measured in chamber
Chamber at 24°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
36.98
± 0.15
2. Chamber at 19°C, ad Libitum Diet First
37.02
± 0.17
Chamber at 19°C, fixed diet
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
36.97
± 0.19
2. Chamber at 19°C, ad Libitum Diet First
36.95
± 0.20
Chamber at 24°C, fasting
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
36.98
± 0.21
2. Chamber at 19°C, ad Libitum Diet First
36.98
± 0.21
Weight Change at 6 MonthsSecondary· 6 months
Weight change from baseline to 6 months
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
0.3
± 5.6
2. Chamber at 19°C, ad Libitum Diet First
-0.5
± 8.1
Weight Change at 12 MonthsSecondary· 12 months
Weight change from baseline to 12 months
Group
Value
95% CI
Chamber at 19°C With Fixed Diet First
1.0
± 8.9
2. Chamber at 19°C, ad Libitum Diet First
-0.6
± 8.9
Adverse events — posted to ClinicalTrials.gov
Time frame: 1 year.
Reporting threshold: 1%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Chamber at 19°C With Fixed Diet First
Serious: 0/24 (0%)
Deaths: 0/24
2. Chamber at 19°C, ad Libitum Diet First
Serious: 0/30 (0%)
Deaths: 0/30
Other adverse events (2 terms — click to expand)
Reaction
System
Chamber at 19°C With Fixed…
2. Chamber at 19°C, ad Lib…
Gastroesophageal reflux disease symptoms at Chamber at 24°C, fixed diet
Gastrointestinal disorders
—
—
Gastroesophageal reflux disease symptoms at Chamber at 19°C, fixed diet
One reason people gain weight is eating more calories from food than what they need for energy over 24 hours. Metabolism is the amount of energy a person uses over 24 hours. Researchers want to study the relationship between changes in metabolism and how much a person eats.
Objectives:
To see how much food a person eats when the body's temperature is cooled. To study how changes in metabolism may alter the amount of food a person eats.
Eligibility:
Healthy people ages 18-55.
Design:
Participants will stay at NIH for 20 days.
During the first 4 days, participants will have:
* Medical exam
* Electrocardiogram
* Blood and urine tests. One blood test includes drinking a sugar solution.
* DXA body composition scan
* Questions about foods they like, physical activity, and personal behavior
* Exercise test on a stationary bicycle
Participants will spend 24-hour periods in a metabolic chamber. The chamber will be at normal room temperature or cooler.
Some times, participants will eat a diet that matches their daily needs (fixed or eucaloric). Other times, they can eat as much as they wish from a vending machine (ad libitum).
Participants will have blood and urine collected.
Participants will swallow an ingestible wireless sensor and wear a small data recorder device.
On the second to last day, participants will stay in the metabolic chamber but only consume water and non-caffeinated sugar-free beverages.
Participants will come back for 1-day visits at six months and one year from the first admission. They will have blood and urine tests, and a DXA scan. They will answer questions on physical activity and food habits.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
NCT05092945 — Brown Adipose Tissue Metabolism in Type 2 Diabetes
· NA
· completed
NCT05107570 — The Effect of Cold Exposure on Energy Expenditure
· NA
· completed
NCT04516018 — Shivering and Glucose Homeostasis
· NA
· completed
NCT04037371 — Environmental Temperature and Human White Adipose Tissue
· completed
NCT03290846 — Secretin Activates Human Brown Fat and Induces Satiation.
· Phase 2, PHASE3
· completed
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise
· NA
· recruiting
NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva
· Phase 1
· recruiting
NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
· Phase 1
· recruiting
NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity
· Phase 1
· recruiting
NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants
· Phase 1
· recruiting
Other National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) trials
Trials by the same sponsor.
NCT07313787 — Effects of Meal Macronutrients on Postprandial Lipids
· Phase 2
· not yet recruiting
NCT07388537 — Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults
· not yet recruiting
NCT05713799 — Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
· Phase 2
· not yet recruiting
NCT05722210 — Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
· not yet recruiting
NCT07191561 — Hepatic Lipid Metabolism-Alcohol Use Disorder
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last refreshed: 4 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02939404.